Clinical Trial Update: Certoparin in Renal Patients Undergoing Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Certoparin in patients undergoing hemodialysis has completed. The study sponsor is Novartis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Certoparin (certoparin)

Snippet

Sponsor: Novartis | Conditions: Renal Dialysis | Phase 3 | Status: COMPLETED